Manchester pharmacogenomics students volunteer at Patients Choice Laboratories
Manchester University students from the master’s degree program in pharmacogenomics are volunteering at Patients Choice Laboratories, an independent clinical laboratory in Indianapolis, to support molecular testing, including COVID-19.
The voluntary program provided by Patients Choice Laboratories offers students the opportunity to use their knowledge and learn new skills in the setting of a clinical laboratory.
“The molecular biology aspects of COVID-19 testing are similar to those used in pharmacogenomics,” said W. Thomas Smith, dean of Pharmacy Programs at Manchester. Pharmacogenomics studies the relationship between an individual’s genes and their response to medications.
“Our students jumped at a chance to use their skills and knowledge to make a difference,” Smith said.
“Patients Choice is excited about partnering with Manchester University students in an effort to bring industry and academia together,” said Brad Moss, president of Patients Choice Laboratories. “The partnership offers students in-depth experience into the clinic laboratory setting which will enrich an already rigorous curriculum at MU.”
For the media
W. Thomas Smith, Pharm.D., J.D.wtsmith@manchester.edu or 260-470-2668
Dave Kisor, Manchester director of pharmacogenomics, dfkisor@manchester.edu
Brad Moss, president, Patients Choice Laboratories
Email: bmoss@pclabsindiana.com
Phone: 317-850-9384
COVID-19 testing at Patients Choice Laboratories:
https://pclabsdx.com/covid-19-press-release-pcldx/
Manchester University, with campuses in North Manchester and Fort Wayne, Ind., provides vibrant and transformative student experiences. Learn more at www.manchester.edu/about-manchester
Our mission
Manchester University respects the infinite worth of every individual and graduates persons of ability and conviction who draw upon their education and faith to lead principled, productive, and compassionate lives that improve the human condition.
April 2020